Abstract
With the aim of analyzing the psychosocial impact of Covid-19 pandemic on society in general and health care workers in particular, we developed a 74-question survey questionnaire which was shared through social media. After analyzing 56,656 responses obtained during the first pandemic peak, the results showed an early and important negative impact on family finances, fear of working with Covid-19 patients and ethical issues related to Covid-19 care among healthcare workers (HCW). We have identified 7 target groups at higher risk of impaired mental health and susceptible to benefiting from an intervention: women, under 42 years of age, people with care burden, socio-economically deprived groups, people with unskilled or unqualified jobs, Covid-19 patients, and HCW working with Covid-19 patients. These results should encourage the active implementation of specific strategies to increase resilience in these groups and to prepare an adequate organizational response.
What is already known?
Studies in small cohorts have reported an important impact of the Covid-19 pandemic on the general population at several levels
According to previous studies in small cohorts, approximately 20% of the population suffered from impaired mental health status due to the pandemic
What are the new findings?
We have studied 56,656 survey questionnaires to assess the impact of the Covid-19 outbreak on health status, family finances, habits, general health and mental health status, and ethics, especially in health care workers
We have identified 7 target groups susceptible to benefitting from an intervention, and which should be taken into account when designing new contention measures against the pandemic
What do the new findings imply?
The design and active implementation of interventions to build individual resilience, especially for the targeted populations described, and preparation of an appropriate organizational response are key
The results obtained in this project could help local and national Governments to design or adjust coping measures against future outbreaks
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04378452
Funding Statement
This work was supported by the Spanish Government-FEDER Funds through CV [CPII18/00031], and funding from the European Union Horizon 2020 research and innovation programme under grant agreement No 847762 through LAC contract.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was reviewed and approved by the corresponding Ethics Committee, the Comite Etic de lHospital Universitari Germans Trias i Pujol; and conformed to the principles embodied in the Declaration of Helsinki. The ethical clearance was obtained before starting the project. The survey was created and shared complying with the European General Data Protection Regulation (GDPR), and all data was processed anonymously. The project is registered in ClinicalTrials.gov under the identifier NCT04378452.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data generated within this project is publicly available at Zenodo.
